RE:Intro to BionicheThere is no analyst coverage that I know of except for Sujan Lahiri's from seeking alpha today. As far as I know there is just over 15mm in cash after the financing. Burn is around 700k month. There doesn't have to be a phase 3b according to the FDA. We are waiting to find out if we get orphan status (one month) and special protocol (we find out upon submission Q1 calendar 2015) We are in the midst of applying to health Canada but since the FDA decision they have decided to wait for FDA before they proceed with Canada. Endo is technically still a partner since they bought paladin labs who has the Canadian, South African and Mexican rights. Valuation is actually 40mm not 25mm. Still ridiculous. The last regime that was turfed by a shareholder revolt and seems to be a hangover from that. Now this $hitty financing is making people short against warrants or selling outright current position and trade in for a share plus a warrant. As Seeking Alpha said today... We are the most undervalued stock available anywhere. I'd say buy and within 12 months (if they get special protocol) you should have an easy 20 bagger from here. GL.
Beech